• Criptomonedas
  • Mercados de Predicción
  • Noticias
  • Trading Agéntico
  • Artículos
  • Ligas

Buscar Criptomonedas

Criptomonedas de tendencia

CoinRithm

Empresa

Entidad legal
Bees-x Limited
Número de empresa
13308136
Constituida en
England and Wales
Domicilio social
Monmouth House, High Street, Watford, England, WD17 1LN

CoinRithm es un servicio de información e investigación operado por Bees-x Limited. No está autorizado por la Financial Conduct Authority (FCA) para realizar actividades reguladas, y nada en este sitio constituye asesoramiento financiero.

Explorar

CriptomonedasMercados de PredicciónNoticiasArtículosAgent ArenaLigas

Funciones

TableroComercio SimuladoTrading AgénticoPortafolioLista de SeguimientoConfiguraciones

Empresa

Sobre NosotrosMetodologiaTérminos de UsoPolítica de PrivacidadPolítica de CookiesDescargo de Responsabilidad

Soporte

Contacto SoporteFAQKit para desarrolladoresDocumentación MCP

Sociales

X (Twitter)FacebookLinkedInTelegramInstagramTikTokYouTube
© 2026 CoinRithm. Reservados todos los derechos.
Disponible en Google PlayDescargar en App Store
  • Inicio
  • MercadosMercados de Predicción
  • Noticias
  • Tablero
  1. Mercados de Predicción
  2. Ciencia
  3. Hantavirus vaccine in 2026?
Hantavirus vaccine in 2026?

Hantavirus vaccine in 2026?

One-OffCiencia6m
PolymarketPolymarketComprobar disponibilidadSin KYC2% de comisión
Probabilidad implícita actual
Sí
Sí 6%
Calidad del mercado

49 / 100

Baja calidad
Volumen 24h

0 €

Liquidez

23,5 mil €

Alta liquidez
Compra / Venta

5.0% / 7.0%

Spread

40.0%

Spread amplio
Cambio 7d

-1.0%

Datos de mercado

Actualizado hace 9 minutos

4 may 26, 14:4431 dic 26, 0:00

Tendencias

Resultado24hProbabilidad

Resultado elegido

Yes6%

Reglas

This market will resolve to "Yes" if any vaccine intended for humans and inoculating against Hantavirus (including Hantavirus Pulmonary Syndrome (HPS) or Hemorrhagic Fever with Renal Syndrome (HFRS)) receives full approval from the U.S.

Polymarket
  • Food and Drug Administration between market creation and December 31, 2026, 11:59 PM ET.
  • Otherwise, this market will resolve to "No".
  • The primary resolution source for this market will be official information from the FDA, including its list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states), however a consensus of credible reporting may also be used.

Mercados Relacionados

Will the US confirm that aliens exist by...?

Will the US confirm that aliens exist by...?

1,2 M €
December 31: 11%PolymarketPOLYMARKET
Where will 2026 rank among the hottest years on record?

Where will 2026 rank among the hottest years on record?

3,7 mil €
2: 62%PolymarketPOLYMARKET
Manifold Markets

Donut Battery is essentially Lithium free?

3,3 mil €
Sí: 20.8%Manifold MarketsMANIFOLD MARKETS
Will the U.S. confirm that aliens exist?

Will the U.S. confirm that aliens exist?

1 mil €
Before 2027: 14%KalshiKALSHI
Manifold Markets

Highest monthly CO2 level at Mauna Loa in first half of 2026

848,9 €
432 or less: 0.4%Manifold MarketsMANIFOLD MARKETS
Manifold Markets

Perfect score achieved by an AI model in the International Math Olympiad (IMO) 2026?

605,1 €
Sí: 81%Manifold MarketsMANIFOLD MARKETS

Activos en estos temas

BitcoinBTC$62,924.04+2.75%EthereumETH$1,661.20+2.41%SolanaSOL$65.34+2.85%DogecoinDOGE$0.0853+2.37%XRPXRP$1.12+1.35%BNBBNB$600.62+2.73%

Noticias Relacionadas

Anthropic’s Claude Tackles Chemistry with NMR Structure AnalysisBlockchain.NewsQuantus’ Q-Day Brings Together Leading Cryptographers, Blockchain Builders, Investors, and Researchers to Prepare for the Post-Quantum FutureBlockchain Reporter

Reglas

This market will resolve to "Yes" if any vaccine intended for humans and inoculating against Hantavirus (including Hantavirus Pulmonary Syndrome (HPS) or Hemorrhagic Fever with Renal Syndrome (HFRS)) receives full approval from the U.S.

Polymarket
  • Food and Drug Administration between market creation and December 31, 2026, 11:59 PM ET.
  • Otherwise, this market will resolve to "No".
  • The primary resolution source for this market will be official information from the FDA, including its list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states), however a consensus of credible reporting may also be used.